Trial Profile
Placebo controlled trial of atomoxetine for treatment of ADHD in marijuana dependent patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2012
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Substance-related disorders
- Focus Therapeutic Use
- 06 Apr 2012 Actual patient number is 38 according to ClinicalTrials.gov.
- 06 Apr 2012 Actual patient number is 38 according to ClinicalTrials.gov.
- 06 Apr 2012 Actual initiation date changed from Sep 2005 to Nov 2005 as reported by ClinicalTrials.gov.